Last reviewed · How we verify
CeraVe, Topical Cream — Competitive Intelligence Brief
phase 3
Topical moisturizer/emollient
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
CeraVe, Topical Cream (CeraVe, Topical Cream) — Austin Institute for Clinical Research. CeraVe Topical Cream restores and maintains the skin barrier by delivering ceramides, hyaluronic acid, and other moisturizing agents to hydrate and protect the stratum corneum.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CeraVe, Topical Cream TARGET | CeraVe, Topical Cream | Austin Institute for Clinical Research | phase 3 | Topical moisturizer/emollient |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Topical moisturizer/emollient class)
- Austin Institute for Clinical Research · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CeraVe, Topical Cream CI watch — RSS
- CeraVe, Topical Cream CI watch — Atom
- CeraVe, Topical Cream CI watch — JSON
- CeraVe, Topical Cream alone — RSS
- Whole Topical moisturizer/emollient class — RSS
Cite this brief
Drug Landscape (2026). CeraVe, Topical Cream — Competitive Intelligence Brief. https://druglandscape.com/ci/cerave-topical-cream. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab